Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › lymphangioleiomyomatosis

Lymphangioleiomyomatosis

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for lymphangioleiomyomatosis

9 trials tracked for lymphangioleiomyomatosis: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 1114 citations.

9Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 7 Phase 1 1
  1. Phase 3 Efficacy and Safety of Sirolimus in LAM Completed · 1,114 cited
  2. Phase 2 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed
  3. Phase 2 LAM Pilot Study With Imatinib Mesylate Completed
  4. Phase 2 Letrozole for Lymphangioleiomyomatosis Completed
  5. Phase 2 Safety of Simvastatin in LAM and TSC Completed
  6. Phase 2 Discovery of Sirolimus Sensitive Biomarkers in Blood Completed
Show 3 more trials
  1. Phase 2 A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Completed
  2. Phase 2 Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial Completed
  3. Phase 1 Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.